SG11201400278TA - New enzyme inhibitor compounds - Google Patents
New enzyme inhibitor compoundsInfo
- Publication number
- SG11201400278TA SG11201400278TA SG11201400278TA SG11201400278TA SG11201400278TA SG 11201400278T A SG11201400278T A SG 11201400278TA SG 11201400278T A SG11201400278T A SG 11201400278TA SG 11201400278T A SG11201400278T A SG 11201400278TA SG 11201400278T A SG11201400278T A SG 11201400278TA
- Authority
- SG
- Singapore
- Prior art keywords
- enzyme inhibitor
- inhibitor compounds
- new enzyme
- new
- compounds
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Immunology (AREA)
- Pulmonology (AREA)
- Cardiology (AREA)
- Diabetes (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Heart & Thoracic Surgery (AREA)
- Dermatology (AREA)
- Rheumatology (AREA)
- Hospice & Palliative Care (AREA)
- Hematology (AREA)
- Oncology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Obesity (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Transplantation (AREA)
- Communicable Diseases (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Gastroenterology & Hepatology (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1115853.2A GB201115853D0 (en) | 2011-09-14 | 2011-09-14 | New enzyme inhibitor compounds |
| PCT/GB2012/052265 WO2013038189A1 (en) | 2011-09-14 | 2012-09-13 | New enzyme inhibitor compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11201400278TA true SG11201400278TA (en) | 2014-05-29 |
Family
ID=44908534
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201400278TA SG11201400278TA (en) | 2011-09-14 | 2012-09-13 | New enzyme inhibitor compounds |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20140275063A1 (en) |
| EP (1) | EP2755975A1 (en) |
| JP (1) | JP2014526495A (en) |
| CN (1) | CN103797012A (en) |
| AU (1) | AU2012308153A1 (en) |
| BR (1) | BR112014005581A2 (en) |
| CA (1) | CA2847266A1 (en) |
| EA (1) | EA023803B1 (en) |
| GB (1) | GB201115853D0 (en) |
| IL (1) | IL231352A0 (en) |
| SG (1) | SG11201400278TA (en) |
| WO (1) | WO2013038189A1 (en) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9150574B2 (en) | 2011-09-14 | 2015-10-06 | Proximagen Limited | Enzyme inhibitor compounds |
| SMT201800443T1 (en) * | 2012-11-20 | 2018-09-13 | Merial Inc | Anthelmintic compounds and compositions and method of using thereof |
| GB201304527D0 (en) | 2013-03-13 | 2013-04-24 | Proximagen Ltd | New compounds |
| GB201304526D0 (en) | 2013-03-13 | 2013-04-24 | Proximagen Ltd | New compounds |
| US20160113893A1 (en) | 2013-06-12 | 2016-04-28 | Proximagen Limited | New therapeutic uses of enzyme inhibitors |
| EP3145925B1 (en) * | 2014-05-19 | 2020-11-04 | Boehringer Ingelheim Animal Health USA Inc. | Anthelmintic compounds |
| US9828140B1 (en) | 2014-07-23 | 2017-11-28 | Gloria Molina | Container with inverted hook-shaped handle |
| GB201416446D0 (en) * | 2014-09-17 | 2014-10-29 | Proximagen Ltd | New enzyme inhibitor compounds |
| GB201416444D0 (en) | 2014-09-17 | 2014-10-29 | Proximagen Ltd | New compounds |
| GB201507031D0 (en) * | 2015-04-24 | 2015-06-10 | Proximagen Ltd | New pharmaceutical salt forms |
| EP3386494A1 (en) | 2015-12-07 | 2018-10-17 | Benevolentai Cambridge Limited | Vap-1 inhibitors for treating pain |
| EP3539966A1 (en) | 2018-03-12 | 2019-09-18 | AbbVie Inc. | Inhibitors of tyrosine kinase 2 mediated signaling |
| CN115666577A (en) * | 2020-03-25 | 2023-01-31 | 拓臻股份有限公司 | Treatment of respiratory conditions |
| US11820754B2 (en) | 2020-08-25 | 2023-11-21 | Eli Lilly And Company | Polymorphs of an SSAO inhibitor |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6143749A (en) * | 1995-06-07 | 2000-11-07 | Abbott Laboratories | Heterocyclic substituted cyclopentane compounds |
| AU2002214505A1 (en) | 2000-11-09 | 2002-05-21 | Biovitrum Ab | New use of 4, 5, 6, 7-tetrahydroimidazo-(4,5-c)pyridine derivatives |
| US6982286B2 (en) | 2001-07-12 | 2006-01-03 | Biotie Therapies Corp. | Carbocyclic hydrazino inhibitors of copper-containing amine oxidases |
| JP4459619B2 (en) * | 2001-10-02 | 2010-04-28 | グラクソスミスクライン・リミテッド・ライアビリティ・カンパニー | Compound |
| AR037211A1 (en) | 2001-11-07 | 2004-10-27 | Schering Corp | HETEROARILO DERIVATIVES AS SUPERIOR LIGANDS FOR ORL-1 NOCICEPTIN RECEPTOR |
| CA2535403A1 (en) | 2003-08-08 | 2005-02-17 | La Jolla Pharmaceutical Company | Inhibitors of semicarbazide-sensitive amine oxidase (ssao) and vap-1 mediated adhesion useful for treatment of diseases |
| EP1730148A4 (en) * | 2004-02-03 | 2009-08-19 | Abbott Lab | Aminobenzoxazoles as therapeutic agents |
| WO2006114180A1 (en) * | 2005-04-25 | 2006-11-02 | Merck Patent Gmbh | Novel aza- heterocycles serving as kinase inhibitors |
| US20070010523A1 (en) * | 2005-06-22 | 2007-01-11 | Chemocentryx, Inc. | Azaindazole compounds and methods of use |
| US20070293548A1 (en) | 2006-03-31 | 2007-12-20 | Wang Eric Y | Inhibitors of semicarbazide-sensitive amine oxidase (SSAO) and VAP-1 mediated adhesion useful for treatment and prevention of diseases |
| GB0610242D0 (en) | 2006-05-23 | 2006-07-05 | Novartis Ag | Organic compounds |
| CN101568527A (en) | 2006-10-31 | 2009-10-28 | 先灵公司 | 2-aminothiazole-4-carboxylic amides as protein kinase inhibitors |
| JP2010512331A (en) | 2006-12-06 | 2010-04-22 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | Glucocorticoid mimetics, methods for their production, pharmaceutical compositions, and uses thereof |
| US20100099673A1 (en) * | 2007-01-17 | 2010-04-22 | Bilodeau Mark T | Decahydroquinoline analogs as cb2 receptor modulators, useful in the treatment of pain, respiratory and non-respiratory diseases |
| GB0725103D0 (en) | 2007-12-21 | 2008-01-30 | Glaxo Group Ltd | Novel compounds |
| WO2009108551A2 (en) * | 2008-02-25 | 2009-09-03 | H. Lundbeck A/S | Heteroaryl amide analogues |
| JP5613671B2 (en) * | 2008-09-16 | 2014-10-29 | プロキシマジェン エルティーディーＰｒｏｘｉｍａｇｅｎ Ｌｔｄ． | Novel compound II |
| JP2012211085A (en) * | 2009-08-12 | 2012-11-01 | Kyowa Hakko Kirin Co Ltd | Hedgehog signal inhibitor |
| GB201004311D0 (en) * | 2010-03-15 | 2010-04-28 | Proximagen Ltd | New enzyme inhibitor compounds |
-
2011
- 2011-09-14 GB GBGB1115853.2A patent/GB201115853D0/en not_active Ceased
-
2012
- 2012-09-13 CN CN201280044629.5A patent/CN103797012A/en active Pending
- 2012-09-13 AU AU2012308153A patent/AU2012308153A1/en not_active Abandoned
- 2012-09-13 US US14/344,436 patent/US20140275063A1/en not_active Abandoned
- 2012-09-13 WO PCT/GB2012/052265 patent/WO2013038189A1/en active Application Filing
- 2012-09-13 JP JP2014530312A patent/JP2014526495A/en not_active Ceased
- 2012-09-13 SG SG11201400278TA patent/SG11201400278TA/en unknown
- 2012-09-13 EA EA201490450A patent/EA023803B1/en not_active IP Right Cessation
- 2012-09-13 EP EP12761791.8A patent/EP2755975A1/en not_active Withdrawn
- 2012-09-13 BR BR112014005581A patent/BR112014005581A2/en not_active IP Right Cessation
- 2012-09-13 CA CA2847266A patent/CA2847266A1/en not_active Abandoned
-
2014
- 2014-03-06 IL IL231352A patent/IL231352A0/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EA201490450A1 (en) | 2014-08-29 |
| CN103797012A (en) | 2014-05-14 |
| WO2013038189A1 (en) | 2013-03-21 |
| EP2755975A1 (en) | 2014-07-23 |
| BR112014005581A2 (en) | 2017-03-21 |
| CA2847266A1 (en) | 2013-03-21 |
| JP2014526495A (en) | 2014-10-06 |
| EA023803B1 (en) | 2016-07-29 |
| IL231352A0 (en) | 2014-04-30 |
| US20140275063A1 (en) | 2014-09-18 |
| GB201115853D0 (en) | 2011-10-26 |
| AU2012308153A1 (en) | 2014-03-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1257823A1 (en) | Metalloenzyme inhibitor compounds | |
| GB201004311D0 (en) | New enzyme inhibitor compounds | |
| HK1198163A1 (en) | Metalloenzyme inhibitor compounds | |
| ZA201309561B (en) | Novel inhibitor compounds of phosphodiestarase type 10a | |
| EP2723730A4 (en) | Metalloenzyme inhibitor compounds | |
| ZA201306580B (en) | Cyclopropylamines as lsd1 inhibitors | |
| IL231352A0 (en) | New enzyme inhibitor compounds | |
| EP2714970A4 (en) | Enzyme quantification | |
| IL231353A0 (en) | New enzyme inhibitor compounds | |
| GB201004179D0 (en) | Enzyme inhibitors | |
| GB201004178D0 (en) | Enzyme inhibitors | |
| AP3529A (en) | Hydroxymethylaryl-substituted pyrrolotriazines as alk1 inhibitors | |
| HK1200840A1 (en) | Dpp-4 inhibitor dpp-4 | |
| HK1199252A1 (en) | Inhibitors of nedd8-activating enzyme nedd8- | |
| ZA201307496B (en) | Novel rock inhibitors | |
| EP2751117A4 (en) | Metalloenzyme inhibitor compounds | |
| GB201114854D0 (en) | Novel rock inhibitors | |
| HK1197057A1 (en) | New lipogenesis inhibitor compounds | |
| HK1191327A1 (en) | Azaspirodecanone compounds as hsl inhibitors hsl | |
| GB201113689D0 (en) | Novel PDE4 inhibitors | |
| GB201114751D0 (en) | Enzyme inhibition | |
| GB201114748D0 (en) | Enzyme inhibition | |
| GB201104399D0 (en) | Novel inhibitors | |
| GB201120474D0 (en) | Inhibitors | |
| GB201004308D0 (en) | New inhibitor compounds |